title: [Can the assay of angiotensin converting enzyme be a marker of observance in cardiology practice?].
authors.affiliation: Service de médecine interne, CHU Timone, Marseille.
authors.forename: G
authors.initials: G
authors.lastname: Bolla
authors.forename: P
authors.initials: P
authors.lastname: Disdier
authors.forename: J F
authors.initials: JF
authors.lastname: Renucci
authors.forename: F
authors.initials: F
authors.lastname: Roux
authors.forename: B
authors.initials: B
authors.lastname: Vaisse
authors.forename: J R
authors.initials: JR
authors.lastname: Harle
authors.forename: L
authors.initials: L
authors.lastname: Poggi
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiller
mesh_terms: D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D010349:Patient Compliance; D007703:Peptidyl-Dipeptidase A / Q000097:blood*
chemical_list: D007703:Peptidyl-Dipeptidase A
vernacular_title: Le dosage de l'enzyme de conversion de l'angiotensine peut-il être un marqueur d'observance en pratique cardiologique?